Activist Investor 13D, 13G Filings


This page shows a list of all the recent 13D/G filings made by Feinberg Larry N. Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

DateForm Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2017‑11‑09 SC 13D/A HNSN / Hansen Medical, Inc. 20,971,982 20,971,982 0.00 27.42 2.81
2017‑11‑02 SC 13D/A MZOR / Mazor Robotics Ltd. 2,219,800 1,358,414 -38.80 5.31 -38.75
2017‑10‑19 SC 13D/A MZOR / Mazor Robotics Ltd. 2,471,378 2,219,800 -10.18 8.67 -15.66
2017‑09‑01 SC 13D/A VRML / Vermillion, Inc. 10,288,587 10,288,587 0.00 17.03 0.00
2017‑08‑31 SC 13D/A VRML / Vermillion, Inc. 9,825,289 10,288,587 4.72 17.03 -1.90
2017‑08‑22 SC 13D/A HNSN / Hansen Medical, Inc. 19,171,447 20,971,982 9.39 26.67 6.89
2017‑07‑05 SC 13D/A HNSN / Hansen Medical, Inc. 15,472,847 19,171,447 23.90 24.95 10.50
2017‑04‑25 SC 13D/A MZOR / Mazor Robotics Ltd. 2,860,836 2,471,378 -13.61 10.28 -23.91
2017‑04‑21 SC 13D/A HNSN / Hansen Medical, Inc. 15,079,422 15,472,847 2.61 22.58 2.45
2017‑02‑22 SC 13D/A VRML / Vermillion, Inc. 9,207,558 9,825,289 6.71 17.36 -3.45
2017‑02‑06 SC 13G/A PACB / Pacific Biosciences of California, Inc. 4,800,162 1,773,048 -63.06 4.2 -19.54
2016‑10‑06 SC 13D/A HNSN / Hansen Medical, Inc. 11,924,487 15,079,422 26.46 22.04 10.26
2016‑10‑06 SC 13D/A BIOL / Biolase, Inc. 11,924,487 15,079,422 26.46 22.04 10.26
2016‑09‑15 SC 13G PACB / Pacific Biosciences of California, Inc. 4,800,162 5.22
2016‑08‑03 SC 13D/A HNSN / Hansen Medical, Inc. 6,529,118 11,924,487 82.64 19.99 -35.60
2016‑08‑03 SC 13D/A BIOL / Biolase, Inc. 11,873,711 11,924,487 0.43 19.99 0.96
2016‑04‑22 SC 13D/A HNSN / Hansen Medical, Inc. 65,291,236 6,529,118 -90.00 31.04 -0.77
2016‑02‑03 SC 13G/A QDEL / QUIDEL Corp. 2,793,784 8.4
2016‑02‑03 SC 13G/A AXDX / Accelerate Diagnostics, Inc. 5,638,647 11.02
2016‑02‑03 SC 13G/A ABEO / Abeona Therapeutics Inc. 0 0.0
2016‑02‑03 SC 13G/A TTHI / Transition Therapeutics Inc. 4,243,146 10.82
2016‑02‑03 SC 13G/A NXTM / NxStage Medical, Inc. 3,282,001 5.15
2016‑02‑03 SC 13G/A MBLX / Metabolix, Inc. 933,620 3.42
2016‑01‑27 SC 13D/A MZOR / Mazor Robotics Ltd. 2,637,772 2,860,836 8.46 13.51 8.34
2015‑11‑12 SC 13D/A BIOL / Biolase, Inc. 11,873,711 19.93
2015‑10‑30 SC 13D/A MZOR / Mazor Robotics Ltd. 2,421,201 2,637,772 8.94 12.47 9.00
2015‑07‑17 SC 13D/A VRML / Vermillion, Inc. 8,695,515 9,207,558 5.89 17.98 -9.65
2015‑06‑30 SC 13D/A MZOR / Mazor Robotics Ltd. 2,421,201 11.44
2015‑06‑26 SC 13G CFRX / ContraFect Corporation 1,773,048 6.92
2015‑05‑19 SC 13D/A HNSN / Hansen Medical, Inc. 65,291,236 31.28
2015‑04‑24 SC 13D/A VRML / Vermillion, Inc. 8,695,515 19.9
2015‑03‑12 SC 13D/A HNSN / Hansen Medical, Inc. 26,790,481 19.99
2015‑03‑09 SC 13D/A BIOL / Biolase, Inc. 11,818,911 19.8